New-to-nature CO<sub>2</sub>-dependent acetyl-CoA assimilation enabled by an engineered B<sub>12</sub>-dependent acyl-CoA mutase.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39592584.
- Also identified by DOI 10.1038/s41467-024-53762-9 and PMC identifier 11599936.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Acetyl-CoA is a key metabolic intermediate and the product of various natural and synthetic one-carbon (C1) assimilation pathways. While an efficient conversion of acetyl-CoA into other central metabolites, such as pyruvate, is imperative for high biomass yields, available aerobic pathways typically release previously fixed carbon in the form of CO<sub>2</sub>. To overcome this loss of carbon, we develop a new-to-nature pathway, the Lcm module, in this study. The Lcm module provides a direct link between acetyl-CoA and pyruvate, is shorter than any other oxygen-tolerant route and notably fixes CO<sub>2</sub>, instead of releasing it. The Lcm module relies on the new-to-nature activity of a coenzyme B<sub>12</sub>-dependent mutase for the conversion of 3-hydroxypropionyl-CoA into lactyl-CoA. We demonstrate Lcm activity of the scaffold enzyme 2-hydroxyisobutyryl-CoA mutase from Bacillus massiliosenegalensis, and further improve catalytic efficiency 10-fold by combining in vivo targeted hypermutation and adaptive evolution in an engineered Escherichia coli selection strain. Finally, in a proof-of-principle, we demonstrate the complete Lcm module in vitro. Overall, our work demonstrates a synthetic CO<sub>2</sub>-incorporating acetyl-CoA assimilation route that expands the metabolic solution space of central carbon metabolism, providing options for synthetic biology and metabolic engineering.
Medical subject headings
- Acetyl Coenzyme A
- Carbon Dioxide
- Cobamides